Refractory Diffuse large B-cell lymphoma NOS

Also known as: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

DrugDrug NameDrug Description
DB16371GlofitamabA bispecific monoclonal antibody directed against CD20 and CD3 which is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma.
DB16222Loncastuximab tesirineAn antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas.
DB12240Polatuzumab vedotinA CD79b antibody conjugate indicated to treat different types of large B-cell lymphoma.
DB11942SelinexorSelinexor is indicated in combination with bortezomib and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. Selinexor is also indicated...
DB15044TafasitamabA CD19-directed cytolytic monoclonal antibody used in the treatment of B-cell malignancies.